Literature DB >> 23325332

Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Assaf Menachem1, Joab Chapman, Yael Deri, Chaim G Pick, Aviva Katzav.   

Abstract

Excessive influx of immunoglobulin (IgG) into the brain has been reported to induce central nervous system (CNS) dysfunction. Depressed patients may exhibit immune activation manifested by elevated inflammatory markers and pro-inflammatory cytokines. The brain and especially the limbic system contain high concentrations of high affinity Fc receptors. We reviewed the literature on this phenomena and present data on the behavioral effects of pooled normal IgG on the brain. Many disease states are associated with depression and we examined whether this may be linked to high IgG influx. Female Balb/C mice were injected intra-cerbroventricularly with human immunoglobulin whole molecule, or human IgG F(ab')2 or Fc fragments. Control mice were injected with saline. The four groups were subjected to behavioral (staircase, forced swimming test, and elevated plus maze) and cognitive tests (passive avoidance test). IgG-injected mice exhibited depression-like behavior as reflected by significantly higher immobility time in the forced swimming test (p < 0.05) and hyperactive behavior as reflected by higher number of stairs climbed in the staircase test compared to controls (p < 0.01). Fc-fragments-injected mice showed hyperactive behavior as reflected by both higher number of stairs climbed and rearing events in the staircase test compared to controls. The results indicate that high levels of normal IgG in the cerebrospinal fluid can cause hyperactivity and depression-like behavior. The mechanism involved in these CNS manifestations include possibly Fc receptor binding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325332     DOI: 10.1007/s12016-013-8357-z

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  72 in total

Review 1.  Intravenous immunoglobulin: exploiting the potential of natural antibodies.

Authors:  Srini V Kaveri
Journal:  Autoimmun Rev       Date:  2012-02-12       Impact factor: 9.754

Review 2.  Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome.

Authors:  Gisele Zandman-Goddard; Joab Chapman; Yehuda Shoenfeld
Journal:  Semin Arthritis Rheum       Date:  2007-01-26       Impact factor: 5.532

3.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra).

Authors:  A H Swiergiel; G N Smagin; L J Johnson; A J Dunn
Journal:  Brain Res       Date:  1997-11-21       Impact factor: 3.252

5.  Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

Authors:  Aviva Katzav; Inna Solodeev; Ori Brodsky; Joab Chapman; Chaim G Pick; Miri Blank; Wei Zhang; Morris Reichlin; Yehuda Shoenfeld
Journal:  Arthritis Rheum       Date:  2007-03

Review 6.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

7.  Characterization of cytokine-induced hyperalgesia.

Authors:  L R Watkins; E P Wiertelak; L E Goehler; K P Smith; D Martin; S F Maier
Journal:  Brain Res       Date:  1994-08-15       Impact factor: 3.252

8.  Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia.

Authors:  Xianyuan Song; Scott Shapiro; David L Goldman; Arturo Casadevall; Matthew Scharff; Sunhee C Lee
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

9.  The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.

Authors:  Aviva Katzav; Yehuda Shoenfeld; Joab Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Authors:  Jae K Ryu; James G McLarnon
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

View more
  4 in total

1.  Splicing landscape of the eight collaborative cross founder strains.

Authors:  Christina L Zheng; Beth Wilmot; Nicole Ar Walter; Denesa Oberbeck; Sunita Kawane; Robert P Searles; Shannon K McWeeney; Robert Hitzemann
Journal:  BMC Genomics       Date:  2015-02-05       Impact factor: 3.969

2.  Influence of multi-walled carbon nanotubes on the cognitive abilities of Wistar rats.

Authors:  Nina V Sayapina; Alexander A Sergievich; Vladimir L Kuznetsov; Vladimir V Chaika; Irina G Lisitskaya; Pavel P Khoroshikh; Tatyana A Batalova; Kostas Tsarouhas; Demetrios Spandidos; Aristidis M Tsatsakis; Concettina Fenga; Kirill S Golokhvast
Journal:  Exp Ther Med       Date:  2016-07-01       Impact factor: 2.447

3.  Immune suppression of IgG response against dairy proteins in major depression.

Authors:  Leszek Rudzki; Dariusz Pawlak; Krystyna Pawlak; Napoleon Waszkiewicz; Aleksandra Małus; Beata Konarzewska; Mirosława Gałęcka; Anna Bartnicka; Lucyna Ostrowska; Agata Szulc
Journal:  BMC Psychiatry       Date:  2017-07-24       Impact factor: 3.630

4.  Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.

Authors:  Minesh Kapadia; Dunja Bijelić; Hui Zhao; Donglai Ma; Ljudmila Stojanovich; Milena Milošević; Pavle Andjus; Boris Šakić
Journal:  Acta Neuropathol Commun       Date:  2017-09-07       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.